ESLA icon

Estrella Immunopharma
ESLA

Overview Fund Activity

13 hedge funds and large institutions have $19.7M invested in Estrella Immunopharma in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
-10
Holders Change %
-43.48%
% of All Funds
0.21%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
4
Increased
3
Reduced
4
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
OCAM
1
Owl Creek Asset Management
New York
$2.62M
2
SIA
2
SkyView Investment Advisors
New Jersey
$1.29M
3
MC
3
Meteora Capital
Florida
$318K
4
LCM
4
Landscape Capital Management
New Jersey
$516K
5
YCM
5
Yakira Capital Management
Connecticut
$104K

Top Sellers

1
BFM
1
Boothbay Fund Management
New York
$0
2
ASM
2
ATW SPAC Management
New York
$0
3
CSS
3
Cubist Systematic Strategies
Connecticut
$209K
4
CH
4
CVI Holdings
Delaware
$0
5
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
WAM
26
Weiss Asset Management
Massachusetts
– -$101K -10,000 Closed
EC
27
Elequin Capital
New York
– -$24K -2,400 Closed
1
2